These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23981003)

  • 21. TLR9 mediates S. aureus killing inside osteoblasts via induction of oxidative stress.
    Mohamed W; Domann E; Chakraborty T; Mannala G; Lips KS; Heiss C; Schnettler R; Alt V
    BMC Microbiol; 2016 Oct; 16(1):230. PubMed ID: 27716055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CpG oligodeoxynucleotides block human immunodeficiency virus type 1 replication in human lymphoid tissue infected ex vivo.
    Schlaepfer E; Audigé A; von Beust B; Manolova V; Weber M; Joller H; Bachmann MF; Kundig TM; Speck RF
    J Virol; 2004 Nov; 78(22):12344-54. PubMed ID: 15507621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CpG motifs to modulate innate and adaptive immune responses.
    Vollmer J
    Int Rev Immunol; 2006; 25(3-4):125-34. PubMed ID: 16818368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CpG oligodeoxynucleotides as DNA adjuvants in vertebrates and their applications in immunotherapy.
    Chaung HC
    Int Immunopharmacol; 2006 Oct; 6(10):1586-96. PubMed ID: 16919831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacterial DNA activates endothelial cells and promotes neutrophil adherence through TLR9 signaling.
    El Kebir D; József L; Pan W; Wang L; Filep JG
    J Immunol; 2009 Apr; 182(7):4386-94. PubMed ID: 19299739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge.
    Krieg AM; Love-Homan L; Yi AK; Harty JT
    J Immunol; 1998 Sep; 161(5):2428-34. PubMed ID: 9725240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CpG DNA in the prevention and treatment of infections.
    Dalpke A; Zimmermann S; Heeg K
    BioDrugs; 2002; 16(6):419-31. PubMed ID: 12463765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel oligodeoxynucleotide agonists of TLR9 containing N3-Me-dC or N1-Me-dG modifications.
    Putta MR; Zhu F; Li Y; Bhagat L; Cong Y; Kandimalla ER; Agrawal S
    Nucleic Acids Res; 2006; 34(11):3231-8. PubMed ID: 16798912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Granulin is a soluble cofactor for toll-like receptor 9 signaling.
    Park B; Buti L; Lee S; Matsuwaki T; Spooner E; Brinkmann MM; Nishihara M; Ploegh HL
    Immunity; 2011 Apr; 34(4):505-13. PubMed ID: 21497117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.
    Vollmer J; Weeratna RD; Jurk M; Samulowitz U; McCluskie MJ; Payette P; Davis HL; Schetter C; Krieg AM
    Immunology; 2004 Oct; 113(2):212-23. PubMed ID: 15379982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The critical DNA flanking sequences of a CpG oligodeoxynucleotide, but not the 6 base CpG motif, can be replaced with RNA without quantitative or qualitative changes in Toll-like receptor 9-mediated activity.
    Sen G; Flora M; Chattopadhyay G; Klinman DM; Lees A; Mond JJ; Snapper CM
    Cell Immunol; 2004; 232(1-2):64-74. PubMed ID: 15922717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CpG oligonucleotides induce an immune response of odontoblasts through the TLR9, MyD88 and NF-kappaB pathways.
    He W; Yu Q; Zhou Z; Wang P
    Biochem Biophys Res Commun; 2010 Aug; 399(2):274-8. PubMed ID: 20655295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A dinucleotide motif in oligonucleotides shows potent immunomodulatory activity and overrides species-specific recognition observed with CpG motif.
    Kandimalla ER; Bhagat L; Zhu FG; Yu D; Cong YP; Wang D; Tang JX; Tang JY; Knetter CF; Lien E; Agrawal S
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14303-8. PubMed ID: 14610275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor effect of OK-432-derived DNA: one of the active constituents of OK-432, a streptococcal immunotherapeutic agent.
    Oshikawa T; Okamoto M; Tano T; Sasai A; Kan S; Moriya Y; Ryoma Y; Saito M; Akira S; Sato M
    J Immunother; 2006; 29(2):143-50. PubMed ID: 16531815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toll-like receptors: cellular signal transducers for exogenous molecular patterns causing immune responses.
    Kirschning CJ; Bauer S
    Int J Med Microbiol; 2001 Sep; 291(4):251-60. PubMed ID: 11680785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Toll-like receptor recognizes bacterial DNA.
    Hemmi H; Takeuchi O; Kawai T; Kaisho T; Sato S; Sanjo H; Matsumoto M; Hoshino K; Wagner H; Takeda K; Akira S
    Nature; 2000 Dec; 408(6813):740-5. PubMed ID: 11130078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CpG DNA as a potent inducer of mucosal immunity: implications for immunoprophylaxis and immunotherapy of mucosal infections.
    Harandi AM; Holmgren J
    Curr Opin Investig Drugs; 2004 Feb; 5(2):141-5. PubMed ID: 15043387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eat dirt: CpG DNA and immunomodulation of asthma.
    Kline JN
    Proc Am Thorac Soc; 2007 Jul; 4(3):283-8. PubMed ID: 17607014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toll-like receptor 9 activation with CpG oligodeoxynucleotides for asthma therapy.
    Kline JN; Krieg AM
    Drug News Perspect; 2008 Oct; 21(8):434-9. PubMed ID: 19034349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CpG motifs in bacterial DNA and their immune effects.
    Krieg AM
    Annu Rev Immunol; 2002; 20():709-60. PubMed ID: 11861616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.